Genetic Technologies Ltd

GTG

Company Profile

  • Business description

    Genetic Technologies Ltd is an Australia-based molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast healthcare and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States. The group has two operating segments: EasyDNA and GeneType/Corporate.

  • Contact

    60-66 Hanover Street
    Fitzroy
    MelbourneVIC3065
    AUS

    T: +61 384127000

    https://www.gtglabs.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    30 June 2026

    Employees

    60

Stocks News & Analysis

stocks

Undervalued Aussie e-commerce winner

Shares attractive due to near term profit margin increase and structural growth.
stocks

Our view on oil prices after Maduro is deposed

We’ve revisited our oil price assumptions after the news from Venezuela.
stocks

Nvidia: Full steam ahead with an impressive array of announcements at CES 2026

Our view of Nvidia at the current share price.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,018.0021.50-0.24%
CAC 408,230.496.94-0.08%
DAX 4025,078.16185.960.75%
Dow JONES (US)49,292.62169.46-0.34%
FTSE 10010,043.0279.71-0.79%
HKSE26,458.95251.50-0.94%
NASDAQ23,602.9155.730.24%
Nikkei 22551,961.98556.10-1.06%
NZX 50 Index13,715.0251.440.38%
S&P 5006,945.821.000.01%
S&P/ASX 2008,695.6027.90-0.32%
SSE Composite Index4,085.772.100.05%

Market Movers